About Pluslife

Technology Platform

넳 넲

Pluslife is a leader in animal diagnostics, specializing in mobile Point-of-Care Testing (mPOCT) with a wide range of applications. Our cutting-edge technology offers accuracy on par with qPCR, while being cost-effective enough for use in primary care settings. We are dedicated to continuous innovation, consistently enhancing our enzymes, technology, and product platforms to remain at the forefront of animal diagnostics. Pluslife's solutions, suitable for use in pet hospitals, pet stores, CDCs, and more, are designed to meet both routine and complex diagnostic needs, ensuring the health and well-being of animals.

Corporate Positioning

 

Revolutionizing and Decentralizing Infectious Disease Diagnosis with Innovative, Rapid, Accurate, and Affordable Molecular POCT Solutions

Independently developed patented technology RHAM

——

Independently developed patented technology RHAM

——

RHAM technology effectively overcomes the shortcomings of non-specific amplification (LAMP), insufficient sensitivity (RPA), long reaction time (NASBA), insufficient compatibility and patent limitation (CRISPR) of similar isothermal amplification technologies, and truly achieves the landing of high sensitivity and high specificity nucleic acid POCT rapid detection.

Autonomous raw material enzyme

——

Autonomous raw material enzyme

——

All product raw materials are self-produced by enzymes, with a new generation of enzyme directed evolution platform and protein expression platform, which can achieve large-scale production of protein raw materials at the level of millions per month.

Autonomous POCT process&fully automated production line

——

Autonomous POCT process&fully automated production line

——

With independent patented technology, the entire production line is automated, and the testing reagent kit can reach a monthly production capacity of millions of people.